ULS UL Solutions Inc.
Services-Testing Laboratories · NYSE · SEC CIK 1901440 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.1%
TTM net income YoY51.3%
TTM EPS YoY50.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin50.6%
Operating margin17.8%
Net margin16.1%
FCF margin15.1%
EBITDA margin23.9%
Returns
ROE35.4%
ROA15.6%
ROIC (approx.)28.5%
Asset turnover0.97x
Leverage & solvency
Liabilities / assets52.9%
Debt / equity0.45x
Current ratio2.09x
Interest coverage20.29x
Cash quality & payout
Operating cash flow / net income1.44x
Accruals ratio-6.8%
Payout ratio22.2%
Capex / revenue8.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $823.00M | $816.00M | $758.00M | $789.00M | $783.00M | $776.00M | $705.00M | $739.00M |
| Cost of revenue | $400.00M | $399.00M | $377.00M | $397.00M | $389.00M | $394.00M | $365.00M | $389.00M |
| Gross profit | $423.00M | $417.00M | $381.00M | $392.00M | $394.00M | $382.00M | $340.00M | $350.00M |
| SG&A expense | $260.00M | $267.00M | $243.00M | $239.00M | $238.00M | $244.00M | $232.00M | $235.00M |
| Operating income | $162.00M | $150.00M | $138.00M | $118.00M | $156.00M | $139.00M | $109.00M | $115.00M |
| Interest expense | $6.00M | $5.00M | $8.00M | $9.00M | $10.00M | $10.00M | $12.00M | $13.00M |
| Pretax income | $160.00M | $338.00M | $129.00M | $105.00M | $146.00M | $125.00M | $94.00M | $92.00M |
| Income tax | $43.00M | $84.00M | $32.00M | $34.00M | $40.00M | $28.00M | $23.00M | $7.00M |
| Net income | $108.00M | $246.00M | $92.00M | $67.00M | $100.00M | $91.00M | $67.00M | $81.00M |
| EBITDA | $211.00M | $196.00M | $185.00M | $169.00M | $202.00M | $185.00M | $154.00M | $162.00M |
| EPS (basic) | 0.53 | 1.22 | 0.46 | — | 0.50 | 0.45 | 0.34 | — |
| EPS (diluted) | 0.53 | 1.21 | 0.45 | — | 0.49 | 0.45 | 0.33 | — |
| Dividends declared per share | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 |
| Weighted avg. shares (diluted) | 204.00M | 204.00M | 204.00M | — | 203.00M | 203.00M | 203.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.02B | $434.00M | $258.00M | $295.00M | $255.00M | $272.00M | $267.00M | $298.00M |
| Receivables | $448.00M | $471.00M | $497.00M | $422.00M | $386.00M | $424.00M | $463.00M | $380.00M |
| Current assets | $1.78B | $1.23B | $1.05B | $1.00B | $995.00M | $1.01B | $998.00M | $921.00M |
| PP&E, net | $791.00M | $766.00M | $711.00M | $699.00M | $663.00M | $649.00M | $631.00M | $631.00M |
| Goodwill | $648.00M | $642.00M | $643.00M | $656.00M | $655.00M | $656.00M | $641.00M | $633.00M |
| Intangibles | $39.00M | $41.00M | $44.00M | $48.00M | $52.00M | $55.00M | $56.00M | $58.00M |
| Total assets | $3.69B | $3.12B | $2.96B | $2.92B | $2.90B | $2.92B | $2.88B | $2.80B |
| Current liabilities | $850.00M | $866.00M | $899.00M | $760.00M | $749.00M | $765.00M | $804.00M | $740.00M |
| Short-term debt | — | — | — | $0 | $0 | $0 | $0 | $50.00M |
| Long-term debt | $764.00M | $301.00M | $357.00M | $491.00M | $544.00M | $608.00M | $653.00M | $692.00M |
| Total debt | $764.00M | $301.00M | $357.00M | $491.00M | $544.00M | $608.00M | $653.00M | $742.00M |
| Total liabilities | $1.95B | $1.50B | $1.62B | $1.63B | $1.68B | $1.81B | $1.89B | $1.87B |
| Shareholders' equity | $1.70B | $1.59B | $1.32B | $1.26B | $1.19B | $1.09B | $970.00M | $904.00M |
| Net debt | -$252.00M | -$133.00M | $99.00M | $196.00M | $289.00M | $336.00M | $386.00M | $444.00M |
| Shares outstanding | — | — | — | 201.03M | — | — | — | 200.17M |
| Cash flow statement | ||||||||
| Operating cash flow | $215.00M | $160.00M | $219.00M | $144.00M | $155.00M | $147.00M | $154.00M | $130.00M |
| Capital expenditure | $61.00M | $69.00M | $69.00M | $58.00M | $46.00M | $42.00M | $51.00M | $58.00M |
| Free cash flow | $154.00M | $91.00M | $150.00M | $86.00M | $109.00M | $105.00M | $103.00M | $72.00M |
| Investing cash flow | -$66.00M | $131.00M | -$61.00M | -$21.00M | -$76.00M | -$57.00M | -$50.00M | -$59.00M |
| Financing cash flow | $436.00M | -$114.00M | -$194.00M | -$82.00M | -$93.00M | -$86.00M | -$135.00M | -$82.00M |
| Depreciation & amortization | $49.00M | $46.00M | $47.00M | $51.00M | $46.00M | $46.00M | $45.00M | $47.00M |
| Stock-based compensation | $23.00M | $25.00M | $12.00M | $11.00M | $15.00M | $14.00M | $8.00M | $7.00M |
| Dividends paid | $30.00M | $29.00M | $29.00M | $26.00M | $26.00M | $26.00M | $26.00M | $25.00M |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.